CICigna Group

NYSE cigna.com


$ 331.45 $ -3.37 (-1.01 %)    

Monday, 15-Jul-2024 15:59:55 EDT
QQQ $ 496.90 $ 1.33 (0.27 %)
DIA $ 402.52 $ 2.04 (0.51 %)
SPY $ 561.53 $ 1.54 (0.28 %)
TLT $ 92.88 $ -1.08 (-1.15 %)
GLD $ 223.86 $ 0.72 (0.32 %)
$ 331.42
$ 337.15
$ 0.00 x 0
$ 0.00 x 0
$ 330.70 - $ 338.58
$ 251.86 - $ 364.21
1,266,462
na
94.15B
$ 0.90
$ 26.01
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions-in-the-us

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on d...

Core News & Articles

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...

 cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

 ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-including-cvs-health-unitedhealth

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies...

 cignas-specialty-pharmacy-leadership-expected-to-drive-long-term-eps-growth-analyst-says

Piper Sandler has initiated coverage on Cigna, highlighting its strong position in the specialty pharmacy market and robust gro...

 piper-sandler-initiates-coverage-on-cigna-group-with-overweight-rating-announces-price-target-of-400

Piper Sandler analyst Jessica Tassan initiates coverage on Cigna Group (NYSE:CI) with a Overweight rating and announces Pric...

Core News & Articles

https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/

Core News & Articles

https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest...

 cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

 cigna-cfo-says-pre-pandemic-norms-had-more-seasonality-in-medical-care-ratio-and-thats-more-of-what-cos-expects-this-year

- Goldman Sachs Conf

 cigna-cfo-says-over-the-next-decade-we-see-a-wave-of-drug-innovation-transpiring

- Goldman Sachs Conf

Core News & Articles

- Goldman Sachs Conf

 cigna-cfo-says-co-expects-the-select-segment-to-be-where-it-gets-the-outsized-growth-in-the-cigna-healthcare-portfolio

- Goldman Sachs Conf

 cigna-cfo-says-co-expects-that-it-will-continue-to-see-elevated-inpatient-activity-throughout-the-entire-2024-calendar-year-outpatient-dynamic-was-impacted-by-change-healthcare-hacks-disruption-of-claims-in-q1

- Goldman Sachs Conf